Daniel Kaul is an Infectious Disease physician affiliated with University of Michigan. OpenAlex indexes 215 publications with 5,413 citations (h-index 38).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 East Medical Center Dr
3rd Floor Taubman Ctr Recp D
Ann Arbor, MI 481095352
Telephone
734-647-5899Registry record last updated 23 Mar 2012.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
80.1%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor16.6%Juluca38%Dovato26%Tivicay25%Isentress12%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor13.2%Triumeq76%Descovy24%Part D<11 patients+ 13 more classes in this area
Cardiovascular
8.8%Statin4.9%Atorvastatin Calcium100%Part D<11 patientsalpha-Adrenergic Blocker2%Doxazosin Mesylate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.7%Proton pump inhibitor2.7%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
Biology of Blood and Marrow Transplantation
2023 - Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing
American Journal of Transplantation
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”